License Delays Introduction of Dapivirine Vaginal Ring

3161 Views Kampala, Uganda

In short
Dr. Betty Kamira, a researcher under the collaboration between Makerere University and John Hopkins University, says during their study they discovered that most girls are worried of getting pregnant and opposed to get HIV infections, which prompted them to develop the Dapivirine Vaginal Ring.

Dapivirine Vaginal Ring is yet to hit the market due to licensing issues. Dapivirine Vaginal Ring is a plastic like material containing 20 milligrams of Pre-exposure prophylaxis- PReP. It is inserted in the vagina before sexual intercourse to prevent Sexually Transmitted Infections and diseases especially HIV/AIDS.

 
Dapivirine Vaginal Ring reduces the chance of HIV infection by 80 percent. Dr. Betty Kamira, a researcher under the collaboration between Makerere University and John Hopkins University, says during their study they discovered that most girls are worried of getting pregnant and opposed to get HIV infections, which prompted them to develop the Dapivirine Vaginal Ring.

 
//Cue in: "There have been…..
Cue out: …Women will use,"//

 
She was speaking at the first annual Public Health Youth Symposium held at Hotel Africana in Kampala on Thursday. Dr. Kamira however notes the Dapivirine Vaginal Ring is not yet on the market due to absence of a trading license.

 
She explains that they are working with International Partnership Microbicides to lobby for the licence to allow them avail the product on the market, adding that they hope to achieve everything by the 2021.
 
//Cue in: "The people who. ….
Cue Out: …the ring or notm,"//

 
Asked how the Dapivirine Vaginal Ring differs from Intrauterine device-IUDs, Dr. Kamira said the Dapivirine Vaginal Ring prevents HIV as well as reduces chances of unwanted pregnancies unlike IUD's, which are only used for birth control.

 
Dr. Kamira says a study conducted under the Makerere University-Johns Hopkins University collaboration in 2014 showed that 27 percent of more than 4,500 African Women between the ages of 18 and 45 who used the ring didn't conceive.
 
A female doctor who attended the symposium and only identified herself as Ruth, said she is among the few people who have used the Dapivirine Vaginal Ring but tests negative every time she removes it. 
 
  
Currently, the women can only use the ring for four weeks and change to another. But Dr. Ruth says studies are still ongoing to find ways of enabling the women to use the ring for more than a month.  
 

According to the 2016 Uganda Population HIV Impact Assessment (UPHIA), HIV prevalence rate stands at 6% compared to 7.3% in 201. This implies that the country has made a significant progress in the National HIV response.